Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Minute Insight: Medtronic’s Extravascular ICD Earns European Approval

Executive Summary

The Aurora extravascular implantable cardioverter defibrillator and the Epsila extravascular lead earned a CE mark supported by results from a global pivotal study.

You may also be interested in...

FDA Approves Medtronic’s 'Extra-Vascular' ICD, The First Of Its Kind

The Aurora EV ICD system provides anti-tachycardia pacing, cardioversion and defibrillation therapies through a lead placed under the breastbone, outside of the heart and veins.

Long-Term Data Affirm Durability Of Medtronic’s EV-ICD

Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. This edition is an update on Medtronic's Extravascular ICD (EV-ICD).

Minute Insight: Medtronic Counters Abbott With New Micra Leadless Pacemakers

About a month after it approved Abbott’s Aveir VR leadless pacemaker, the FDA approved two new models of Medtronic’s Micra leadless pacemaker.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts